March 2025

145 Articles

No Section

Some comments on Tecovirimat and mpox

1 March 2025
Author(s): Salvatore Chirumbolo, Umberto Tirelli

The paper by Rizk et al., "Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations," presents a detailed discussion on the antiviral Tecovirimat (TPOXX) and... more

Hydroxychloroquine use in patients with primary immune thrombocytopenia and antiphospholipid antibodies

13 January 2025
Author(s): Fernando Porto, Artur Saldanha, Erica Okazaki, Paula Villaça, Fernanda A. Orsi

The prevalence of antiphospholipid antibodies (aPL) among patients with immune thrombocytopenia (ITP) is high, at 20 % or higher according to previous studies [1,2].

Clinical Insights

The emperor's new clothes and the case of vitamin D and cardiovascular risk. A few thoughts after the guidelines of the American Society of Endocrinology

14 February 2025
Author(s): Claudio Cimminiello

As in the famous Christian Andersen fairy tale, the recent guidelines of the American Society of Endocrinology [1] have confirmed that the king is naked, significantly diminishing the role of... more

Aspirin-free strategies after percutaneous coronary intervention: Old habits, consolidated evidence and future perspectives

18 January 2025
Author(s): Antonio Landi, Stefano De Servi, Leonardo De Luca

Antithrombotic therapy represents the mainstay of the pharmacological treatment in patients with coronary artery disease undergoing percutaneous coronary intervention (PCI) [1]. Dual antiplatelet... more

Redefining giant cell arteritis: From current practices to future paradigms

9 December 2024
Author(s): Alessandro Tomelleri, Nicola Farina, Lorenzo Dagna

The management of patients with giant cell arteritis (GCA), the most common vasculitis in adults, has undergone significant transformation over the past decade [1]. This shift has been primarily... more

Commentary

Sodium-glucose co-transporter 2 inhibitors in acute heart failure: What are you waiting for?

6 March 2025
Author(s): Herminio Morillas, Josep Comin-Colet

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) were initially discovered as a compound present in roots, leaves and fruits of the apple tree in 1835. However, it was not until the beginning of... more

The prothrombotic effects of Lipoprotein (a) and atherosclerosis

3 March 2025
Author(s): Avishay Elis

Lipoprotein (a) [Lp(a)] is a plasma lipoprotein consisting of a cholesterol-rich LDL particle with one molecule of apolipoprotein B100 and an additional protein which has sequence homology with... more

The misalignment between chronotype and sleep time: Friend or foe?

3 March 2025
Author(s): Eleonora Tobaldini, Angelica Carandina, Nicola Montano

We spend approximately one third of our lifetime in sleep, a complex physiological process which is an established health determinant. In the last decades, it has been demonstrated that reduction of... more

Catheter ablation of atrial fibrillation in older patients: The need for a comprehensive evaluation and management

1 March 2025
Author(s): Mario Bo, Marco Proietti, Roberto Presta

Atrial fibrillation (AF) affects approximately one-third of individuals aged 80 years and over and is associated with a wide range of adverse clinical outcomes, including heart failure (HF), ischemic... more

Redefining thiamine requirements in alcohol use disorder: Aligning treatment with neurocognitive needs

28 February 2025
Author(s): Di Sario Giovanna, Dionisi Tommaso, Addolorato Giovanni

Alcohol Use Disorder (AUD) is a pervasive condition that often presents with marked neurocognitive consequences. From mild executive and memory deficits to severe conditions such as Wernicke–... more

Ischemic heart failure etiology: A misleading definition?

28 February 2025
Author(s): Alexander Schmitt, Michael Behnes, Ibrahim Akin, Tobias Schupp

Heart failure (HF) remains a leading cause of morbidity and mortality despite advances in interventional and pharmacological therapies [1,2]. Beyond the classification based on left ventricular... more

Atrial fibrillation screening: The importance of the patient perspective

24 February 2025
Author(s): Jacopo Francesco Imberti, Davide Antonio Mei, Giuseppe Boriani

Atrial fibrillation (AF) is the most common cardiac arrhythmia, with its prevalence increasing significantly in older adults and individuals with comorbidities [1]. Beyond being a major contributor... more

Sodium bicarbonate in metabolic acidosis: A never-ending story?

24 December 2024
Author(s): Giovanna Guiotto

Is it useful to treat metabolic acidosis with bicarbonate or not? This question is still one of the hot topics that doctors deal with in their daily clinical practice, mainly due to the lack of clear... more

Pulmonary metastases and bleeding in the anticoagulated oncology patient with thrombosis: is the risk solely influenced by the location of distant disease?

20 December 2024
Author(s): Manuel Sánchez Cánovas, Javier López Robles

The article by García-García V et al. [1], published in this issue of the European Journal of Internal Medicine,provides a valuable exploration of hemorrhagic complications in cancer-associated... more

Primordial prevention of hypertension

8 December 2024
Author(s): Claudio Ferri

Periculum in mora

Internal Medicine Flashcard

Linear lesions on the chest

3 February 2025
Author(s): Pei-Chun Weng, Pei-Rong Gao

A 70-year-old man with a history of lung adenocarcinoma was admitted to our hospital for chemotherapy. During his hospitalization, eruptive papules with a dermatomal distribution developed on his... more

When skin and lung meet

30 January 2025
Author(s): Sara Piciucchi, Stefano Oldani, Venerino Poletti

A 50-year-old male, heavy smoker (>30 p/Y), presented to E.R. because of chest pain. In his recent clinical history, he had relapsing papular-purpuric small lesions in the limbs, trunk and arms... more

A man with trismus and decubitus ulcers

21 January 2025
Author(s): Rika Okamoto, Masaki Itagane, Mitsuyo Kinjo

A 65-year-old man with a history of binge drinking who had engaged in gardening was brought to our hospital for lethargy. On physical examination, temperature was 35.0 °C, blood pressure was 70/50... more

A 73-year-old man with purpura and fever

15 January 2025
Author(s): Ivânia Soares, Inês Pereira Amaral, Paulo Filipe

A 73-year-old man presented to our dermatology department with a four-week history of palpable purpura on the lower limbs. His medical history included a suspicion of polymyalgia rheumatica based on... more

An uncommon and unexpected cause of chest pain: When stockings become trauma

9 January 2025
Author(s): Janneke JC Bastings, Renée Brüggemann, Bart Spaetgens

An 80-year-old woman presented to the emergency department (ED) with acute sternal pain that began after removing her compression stockings. Three days earlier, she experienced a similar episode... more

Female patient with telangiectasia, epistaxis and pulmonary arteriovenous malformation

9 December 2024
Author(s): Fırat Akagunduz, Feride Yagmur Akagunduz, Fergun Yılmaz, Haner Direskeneli

A 55-years-old female patient was admitted to our clinic with a long-standing complaint of epistaxis. She had no medical history and was not taking any medications. Both her children had nosebleeds.... more

Generalized bullous fixed drug eruption

3 December 2024
Author(s): Li Chen, Junfeng Zhou, Lei Yao

A 73-year-old female presented with a diffuse rash accompanied by itching for 3 days. She had taken levofloxacin orally for a cough one day before the rash developed. She had a 16-year history of... more

Esophagitis in an immunocompetent patient: A diagnostic challenge

3 December 2024
Author(s): Shiori Kitaya, Takahiro Yoshinobu, Hajime Kanamori

A 65-year-old man with Parkinson's disease was admitted to hospital for continuous subcutaneous infusion of levodopa/carbidopa. On day 6 of hospitalization, he developed pharyngalgia, sensation of... more

Man with red eyes

1 December 2024
Author(s): Naoya Ishibashi, Tomotaka Takanosu

A 71-year-old male presented to our hospital with vertigo. The supine roll test induced vertigo, leading to a diagnosis of left horizontal semicircular canal benign paroxysmal positional vertigo (... more

Invited Review Article

What is new in the management of coeliac disease?

1 February 2025
Author(s): Mohamed G Shiha, David S Sanders

Coeliac disease is a chronic immune-mediated disorder triggered by gluten ingestion in genetically predisposed individuals [1]. It is characterised by immune-mediated inflammation and damage to the... more

Treat the patient, not the disease: The embolic stroke of undetermined source as an opportunity to optimize cardiovascular prevention in a holistic approach

23 October 2024
Author(s): George Ntaios, Mayank Dalakoti

“It is much more important to know what sort of patient has a disease than what sort of disease a patient has.”“The good physician treats the disease; the great physician treats the patient who has... more

Letter to the Editor

Building on the utily study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections. Author's reply

8 March 2025
Author(s): Lorenzo Onorato, Margherita Macera, Caterina Monari, Nicola Coppola

Dear Editor,

More on peripheral artery disease and air pollution. Author's reply

7 March 2025
Author(s): Chiara Di Blasi, Alberto Maria Settembrini, Massimo Stafoggia, Matteo Renzi, Pier Mannuccio Mannucci

Dear Editor,

Critical considerations for sodium bicarbonate therapy in metabolic acidosis: Addressing confounding factors and methodological limitations

5 March 2025
Author(s): Danyang Liu

I recently read the paper by Tong et al., which explores the clinical effects of sodium bicarbonate (SOB) therapy in metabolic acidosis, focusing on the interaction between baseline chloride levels... more

Utilizing D-dimer levels for predicting survival probability in unplanned hospital admissions: Insights from a 5-year nationwide population-based register study

4 March 2025
Author(s): Mikkel Brabrand, Marianne Fløjstrup, Søren Bie Bogh, Tim Cooksley, Christian Hans Nickel

Although the most common clinical use of D-dimer measurements is to rule out thromboembolic disease [1], it is also elevated in several other serious illnesses and raised levels are associated with a... more

Evidence that adequate provision of vitamin D reduces cardiovascular disease risks

3 March 2025
Author(s): William B. Grant, Barbara J. Boucher

We read with interest the clinical insight by Cimminiello regarding the role of vitamin D and cardiovascular risk [1]. He dismissed the epidemiological evidence that vitamin D deficiency is... more

Why doesn't sepsis rhyme with Internal Medicine?

26 February 2025
Author(s): Chiara Casarsa, Filippo Mearelli, Alessio Nunnari, Francesca Spagnol, Stefano Di Bella

I am writing to share some reflections on the challenges that internists face in the management of sepsis, a complex and multifactorial condition requiring a multidisciplinary approach. Despite the... more

Effect of newer glucose-lowering medications on chronic obstructive pulmonary disease exacerbations among individuals with type 2 diabetes

22 February 2025
Author(s): Paschalis Karakasis, Dimitrios Patoulias, Nikolaos Fragakis, Ricardo Gómez-Huelgas

Type 2 diabetes mellitus (T2D) and chronic obstructive pulmonary disease (COPD) are prevalent chronic conditions that frequently coexist, contributing to significant morbidity and healthcare burden... more

Non-statistical significance and clinical relevance: Are we chasing shadows in the air pollution-peripheral artery disease debate?

21 February 2025
Author(s): Stephan Peronard Mayntz, Kasper Emil Rosenbech

The impact of air pollution on cardiovascular diseases has been a subject of extensive research, with compelling evidence linking long-term exposure to pollutants such as particulate matter (PM2.5),... more

Gut dysbiosis and leaky gut syndrome in moderately impaired amyotrophic lateral sclerosis patients

20 February 2025
Author(s): Laura Comini, Davide Antonio Di Pietro, Adriana Olivares, Enrica Bertella, Michele Vitacca

Dear Editor,

Hemoglobin levels for the diagnosis of polycythemia vera: How high is high enough?

17 February 2025
Author(s): Ugur Koca, Enes Seyda Sahiner, Ozge Soyer Kosemehmetoglu, Tekin Guney, Betul Erismis

The World Health Organization (WHO) diagnostic criteria for Polycythemia Vera (PV), initially published in 2001 and 2008, were last revised in 2016. According to these criteria, evaluation for PV is... more

Evolution of care pathways in clinical practice guidelines for heart failure

17 February 2025
Author(s): Quirós-López R, Estupiñán-Romero F, Millán-Ortuondo E, Bernal-Delgado E, Jiménez-García N

In the context of the increasing complexity of patients with heart failure (HF) and the rapid expansion of available therapies, clinical practice guidelines (CPGs) have become indispensable for... more

Direct oral anticoagulants guided by CHA2DS2-VASc stratification for stroke prevention in patients with device-detected atrial fibrillation

15 February 2025
Author(s): Zhengbiao Xue, Song Liao, Haiye Fan, Yu Shen, Zhi Nie

Atrial fibrillation (AF) significantly increases stroke risk, with affected individuals having a fivefold higher likelihood compared to the general population. Oral anticoagulation (OAC),... more

Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients

14 February 2025
Author(s): Claudia Stöllberger, Raphael Wilfing, Josef Finsterer, Birke Schneider

Sodium-Glucose Cotransporter2-inhibitors (SGLT2i) were developed for treating diabetic patients. Empagliflozin and dapagliflozin, frequently prescribed SGLT2i, are now also recommended for... more

Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation

9 February 2025
Author(s): Shan Zeng, Wulamiding Kaisaier, Chen Liu, Wengen Zhu

Dear Editor,

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome. Author's reply

8 February 2025
Author(s): Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti

We thank García-Martí et al. for the interest in our study recently published in the European Journal of Internal Medicine [1], and here we provide further analysis following their stimulating... more

Rising ischemic stroke-related mortality among young adults in the United States: Insights from CDC WONDER

8 February 2025
Author(s): Usama Qamar, Farhan Naeem, Maaz Asif, Waleed Qamar, Eisha Mazhar

Ischemic Stroke-related mortality among young adults aged 25–64 years in the United States from 1999 to 2020.

Bedside CEUS: A feasible option to consider

6 February 2025
Author(s): Andrea Boccatonda, Alice Brighenti, Valeria Tiraferri, Rossella Loiacono, Carla Serra

Contrast-enhanced ultrasound (CEUS) is widely used for assessing the perfusion of specific organs or lesions. While CEUS has been extensively studied in outpatient settings, its use as a bedside... more

Tecovirimat and mpox: A regulatory balancing act between hope, hurdles, and high-risk populations

3 February 2025
Author(s): John G. Rizk, Giuseppe Lippi, Brandon M. Henry, Kin Israel Notarte, Youssef Rizk

Tecovirimat (marketed as TPOXX in the United States and other regions) is an antiviral drug that targets orthopoxviruses, including smallpox, monkeypox (now mpox), and cowpox. Tecovirimat inhibits... more

Disability and caregivers in Italy: Results from an online survey

3 February 2025
Author(s): Sergio Harari, Antonella Caminati, Luigi Ripamonti, Paolo Marveggio, Pier Mannuccio Mannucci

Disability is a condition with a significant impact on the quality of life of patients, on families who are often acting as their caregivers and on the society at large, with important economic... more

Building on the UTILY Study: Exploring uncharted aspects of multidrug-resistant pathogens in urinary tract infections

1 February 2025
Author(s): Heng Xiao, Wen Xiao, Xinmin Deng

We have carefully reviewed the article by Onorato et al., published in the European Journal of Internal Medicine [1]. The study provides important insights into the prevalence of multidrug-resistant... more

Frailty, disability and patient-reported outcomes in apixaban users

30 January 2025
Author(s): Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni, APULEIO Study Investigators

atrial fibrillation (AF) is the arrhythmia most frequently diagnosed in older patients with a prevalence higher than 10 % in subjects ≥70 years [1]. The incidence of venous thromboembolism (VTE),... more

Mortality in the first 24 hours after admission in the intensive care unit

30 January 2025
Author(s): Rita Pinto Medeiros, Rita Pereira, Carla Teixeira

Dear Editor,

Disease activity and disability influence CV risk estimation and management of rheumatoid arthritis patients

30 January 2025
Author(s): Elena Bartoloni, Fabio Cacciapaglia, Gian Luca Erre, Elisa Gremese, Andreina Manfredi, Matteo Piga, Garifallia Sakellariou, Francesca Romana Spinelli, Ombretta Viapiana, Fabiola Atzeni, Cardiovascular Obesity and Rheumatic DISeases (CORDIS) Study Group of the Italian Society for Rheumatology (SIR)

We sincerely appreciate Shoulin Dou et al.'s interest in our article, and we are grateful for their constructive comments, which have certainly contributed to raising awareness of the significant... more

Extra-articular manifestations in rheumatoid arthritis: Incidence and predisposing factors. Author's reply

28 January 2025
Author(s): Lotta Ljung, Solbritt Rantapää-Dahlqvist

We appreciate that Wang, Wu and Li [1] have taken an interest in our publication on patients with early rheumatoid arthritis (RA) developing extra articular (ExRA) disease [2]. ExRA manifestations... more

Telerehabilitation in patients with long COVID-19 syndrome

20 January 2025
Author(s): Shige Li, Wenbo Dong, Bing Dai, Wei Wang, Wei Tan

Post-acute sequelae of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) disease (COVID-19), known as long COVID syndrome, is defined as new symptoms that occur beyond 3 months after... more

Obesity in Europe: Less impact on chronic diseases thanks to internists?

20 January 2025
Author(s): Livio Garattini, Antonino Mazzone

Defined by the WHO as the ‘new epidemic of the 21st century’, nowadays obesity has become an international public health issue [1], since it can cause a wide range of diseases and a growth in both... more

Trends in industry-sponsored research payments to internist principal investigators

17 January 2025
Author(s): Aurora J. Grutman, Zeyad Hammadeh, Joseph G. Cheaib, Evans K.H. Brown, Misop Han

In the United States, the Physician Payments Sunshine Act, passed by Congress as part of the 2010 Affordable Care Act, has brought greater transparency to financial relationships between industry and... more

Optimal BMI cutoff for lean MASLD/MetALD and adverse hepatic outcomes in East-Asian populations

13 January 2025
Author(s): Byungyoon Yun, Juyeon Oh, Heejoo Park, Beom Kyung Kim, Jin-Ha Yoon

Nonalcoholic fatty liver disease (NAFLD) is a primary contributor to hepatocellular carcinoma (HCC)/liver cirrhosis (LC), affecting ∼30 % of the global population. Its incidence is rising parallel to... more

Refining insights into rheumatoid arthritis-associated liver dysfunction: Opportunities for methodological advancements and clinical implications

13 January 2025
Author(s): Zhongxing Liu, Peng Guo, Guohong Xiang, Lincheng Duan

We read with great interest the article by Arias-de la Rosa et al., published in the European Journal of Internal Medicine [1]. This study provides valuable evidence that patients with rheumatoid... more

Vaginal self-sampling for human papillomavirus to improve cervical cancer screening in patients with immune-mediated inflammatory diseases

12 January 2025
Author(s): Tiphaine Goulenok, Chrystelle François, Valentine Marie Ferré, Arthur Mageau, Karim Sacré, APOSY Study Group

Dear Editor,

Reevaluating hypoxia and cancer as determinants of prognosis in COPD and Takotsubo syndrome

12 January 2025
Author(s): Gonzalo García-Martí, Ravi Vazirani, Hernán Mejía-Rentería, Iván J. Núñez-Gil

Dear Editor,

Internists at the frontline of epidemic viral illnesses: From tiredness to preparedness

9 January 2025
Author(s): Fabian Patauner, Raffaella Gallo, Emanuele Durante-Mangoni, Lorenzo Bertolino

In the wake of the coronavirus disease 2019 (COVID-19) pandemic, who would reasonably declare that a time will ever come «to close the book on infectious diseases»? Indeed, new viral threats are... more

The evolving role of head up tilt test: New protocol and indications for optimizing the care of syncope patients

3 January 2025
Author(s): Vincenzo Russo, Erika Parente, Angelo Comune, Gerardo Nigro, Michele Brignole

Dear Editor, we read with great interest the metanalysis by Guida et al. [1] about the diagnostic held of head up tilt test (HUTT) in patients with suspected vasovagal (VVS) syncope. The authors... more

Rituximab in Immune-mediated thrombotic thrombocytopenic purpura

2 January 2025
Author(s): Jie Li, Jiashuo Guo, Ruirui Yuan, Liying Xue

Thrombotic thrombocytopenic purpura (TTP) is a rare and potentially fatal thrombotic microangiopathy, defined by a mechanical hemolytic anemia, severe thrombocytopenia, and visceral ischemia due to... more

Associations of cardiovascular health and exercise capacity with moderate-to-vigorous physical activity prior to enrolment to cardiac rehabilitation in coronary artery disease patients

30 December 2024
Author(s): Tim Kambič, Esmée A. Bakker, Thijs M.H. Eijsvogels, Vedran Hadžić, Mitja Lainscak

Exercise training is a core component of cardiac rehabilitation (CR) and is associated with improvement in (sub)maximal exercise capacity, quality of life, and a reduction in the risk of re-... more

Refining the understanding of cardiovascular risk following COPD exacerbations: Opportunities for stratified and multidisciplinary approaches

24 December 2024
Author(s): Rujian Yu, Lamei Zou

We have carefully reviewed the article by Calabria et al., published in the European Journal of Internal Medicine [1]. This study, based on a comprehensive database analysis, highlights the... more

Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients

24 December 2024
Author(s): Yinfang Wu, Qi Zhao

The study by Paiva and colleagues [1] provides valuable insights into intra-abdominal infections (IAI) in immunocompromised intensive care unit (ICU) patients, highlighting similarities and... more

Analysis of “characteristics of familial mediterranean fever disease after 65 years of age”

18 December 2024
Author(s): Kazim Besirli

I have read the article “Characteristics of Familial Mediterranean fever (FMF) after 65 years of age” with great interest. The study provides valuable insights into the clinical features and... more

The potential impact of educational attainment on NAFLD risk. Author's reply

14 December 2024
Author(s): Florian Koutny, Elmar Aigner, Bernhard Wernly

We thank Ke-qian Chen et al. and the European Journal of Internal Medicine for the opportunity to engage in a constructive discussion about the relationship between educational attainment and non-... more

Revisiting the association between air pollution and peripheral artery disease: Evidence from mendelian randomization analysis

14 December 2024
Author(s): Zhen Deng, Lincheng Duan, Kai Wang

We read with great interest the article by Di Blasi et al., published in the European Journal of Internal Medicine [1]. This well-designed study provides significant evidence on the association... more

Hypertension – a global problem requiring a comprehensive approach

12 December 2024
Author(s): Agnieszka Zalewska, Anna Litwińska-Kmiecik, Alicja Wiśniewska

We read with great interest a recently published study by Rikuta Hamaya, Molin Wang, Ellen Hertzmark, et al. regarding modifiable lifestyle factors in the primordial prevention of hypertension [1].... more

Risk for hospital-treated infections in dermatitis herpetiformis and coeliac disease

12 December 2024
Author(s): Camilla Pasternack, Matti Karppelin, Kaisa Hervonen, Katri Kaukinen, Teea Salmi, Celiac Disease Study Group

Dear Editor,

Risk of injurious falls in older people with atrial fibrillation

10 December 2024
Author(s): Anna Litwińska-Kmiecik, Agnieszka Zalewska

Dear editor,

Use of betablockers in post-myocardial infarction patients in a real-world setting

9 December 2024
Author(s): Marta Baviera, Anna Zanovello, Luisa Ojeda-Fernández, Mauro Molteni, Claudio Cimminiello

For many years, the main guidelines have been recommending the use of betablocker therapy in patients after myocardial infarction (MI) [1,2]. This recommendation entails a high class and grade for... more

Prognostic impact of different triggers in patients with Takotsubo syndrome and chronic obstructive pulmonary disease. Author's reply

9 December 2024
Author(s): Luca Arcari, Giacomo Tini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti

We thank the authors for the interest in our study recently published in the journal [1]. In that, we focused specifically on patients with takotsubo syndrome (TTS) and chronic obstructive pulmonary... more

High-risk allogeneic stem cells transplantation in advanced age patients with uncontrolled sickle cell disease

8 December 2024
Author(s): Frederic Garban, Caroline Makowski, Claude Eric Bulabois, Laurence Bouillet, Mathieu Meunier

Sickle cell disease (SCD) is a recessive monogenic disease where a single nucleotide mutation of the HBB gene, encoding the β-globin chain of hemoglobin (Hb), leads to the synthesis of HbS.... more

Measuring the risk of clinical adverse events (RISK ACE) by quantifying liver function: A patient-centric model

4 December 2024
Author(s): John Kittelson, Michael P. McRae, Gregory T. Everson

Identifying the patients with compensated advanced chronic liver disease (cACLD) who are at risk for clinical decompensation is a goal of clinical management [1]. Early detection of those at risk for... more

Clarifications and enhancements for cardiovascular risk study in metabolic dysfunction-associated steatotic liver disease

3 December 2024
Author(s): Yinfang Wu, Weixing Xu

This study by Shibata et al. [1] investigated the risk of major adverse cardiac events (MACE) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and employed a... more

Extra-articular manifestations in rheumatoid arthritis: Incidence and predisposing factors

2 December 2024
Author(s): Jiaxu Wang, Jigong Wu, Liqi Li

The research by Lotta Ljung et al. [1] offers valuable insights into extra-articular manifestations (ExRA) in rheumatoid arthritis (RA) yet has room for improvement. The questionnaire-based approach... more

Seasonality of diabetic ketoacidosis in hot climate

28 November 2024
Author(s): Fahmi Abu Ghalion, Mai Ofri, Victor Novack, Lena Novack

Diabetic ketoacidosis (DKA) is a life-threatening condition arising from an absolute or relative insulin deficiency, leading to hyperglycemia and ketone body accumulation in the blood with metabolic... more

Prognostic impact of different triggers in patients with Takotsubo syndrome and chronic obstructive pulmonary disease

28 November 2024
Author(s): Anna Litwińska-Kmiecik, Agnieszka Zalewska, Alicja Wiśniewska

We read with great interest a recently published study by Luca Arcari, Giacomo Tini, Michela Zuccanti, et al. regarding clinical characteristics and outcomes of Takotsubo syndrome (TTS) in patients... more

Diagnostic yield of head-up tilt testing in suspected vasovagal syncope

28 November 2024
Author(s): Pietro Guida, Federica Troisi, Antonio Di Monaco, Massimo Iacoviello, Massimo Grimaldi

Vasovagal syncope (VVS) is the most frequent form of syncopal spells characterized by a reflex causing hypotension and often bradycardia, usually elicited by prolonged standing or exposure to... more

Validating ChatGPT's role in systematic reviews and meta-analyses: A case study on GLP-1 receptor agonists and all-cause mortality

28 November 2024
Author(s): Lefteris Teperikidis, Paschalis Karakasis, Dimitrios Patoulias, Aristi Boulmpou, Dimitrios Kouzoukas, AIMES – AI for Meta-Analysis and Evidence Synthesis

Dear Editor,

Enhancing cardiovascular risk management in rheumatoid arthritis: From medication adherence to multidisciplinary interventions

26 November 2024
Author(s): Shulin Dou, Wei Fang, Wei Wang, Hailiang Wang

We carefully read the article by Cacciapaglia et al. published in the European Journal of Internal Medicine [1]. This study reveals the suboptimal adherence to lipid-lowering therapy prescriptions in... more

Enhancing hypertension prevention research: Insights and opportunities for social work interventions

25 November 2024
Author(s): Ruyi Zhou, Senlin Ye, Jinli Liu, Lincheng Duan

We read with great interest the recent article by Hamaya et al. published in the European Journal of Internal Medicine [1]. The Authors conducted a comprehensive analysis of the impact of lifestyle... more

GLP-1 receptor agonists for the treatment of obstructive sleep apnea and obesity

15 November 2024
Author(s): Livia Romariz, Beatriz Araújo, Lucas M. Barbosa, Riddhi Jain, Carolina C. Porto Silva Janovsky, Obesity Study Group

Obstructive sleep apnea (OSA) syndrome is a common disorder of repeated upper airway collapse during sleep, leading to recurrent hypoxia and hypercapnia [1]. Continuous positive airway pressure (CPAP... more

Switching from hospital centered to community based, person centered and integrated social health and care systems; Mission impossible or key objective?

14 November 2024
Author(s): Lavinia Gentile, Giuseppe Liotta, Edoardo Carnevale, Stefano Orlando, Leonardo Palombi

Length of Stay (LOS) is a widely recorded metric used in hospital management and considered an important indicator of healthcare efficiency [1]. Despite its strategic value and one of the longest... more

The potential impact of educational attainment on NAFLD risk

11 November 2024
Author(s): Ke-qian Chen, Shu-zhi Wang, Zong-bao Wang, Hai-bo Lei, Xiang Liu

We read with great interest the article by Florian Koutny and his colleagues, recently published in the European Journal of Internal Medicine [1]. In this article, Florian Koutny and his colleagues... more

Refining metabolic health assessment in inflammatory bowel disease risk prediction

29 October 2024
Author(s): Yinfang Wu, Weixing Xu

Mi et al.'s investigation [1], drawing upon the United Kingdom (UK) Biobank resource, delves into the interplay between metabolic health and genetic predisposition to inflammatory bowel disease (IBD... more

Characteristics of familial Mediterranean fever after 65 years of age

29 October 2024
Author(s): François Rodrigues, Léa Savey, Marion Delplanque, Laurence Cuisset, Sophie Georgin-Lavialle

Dear Editor,

Co-management hospitalist services for neurosurgery. Where are we?

27 September 2024
Author(s): Ombretta Para, Joel Byju Valuparampil, Alberto Parenti, Carlo Nozzoli, Alessandro Della Puppa

Dear Editor, the increase in the average age of the population and in the prevalence of chronic comorbidities has made healthcare extremely difficult and sometimes with difficult home management [1,2... more

Factors associated to multiple chronic conditions in internal medicine patients

20 September 2024
Author(s): Marco Vincenzo Lenti, Carmine Frenna, Alice Silvia Brera, Catherine Klersy, Gino Roberto Corazza, SMAC Study group

Dealing with patients with multiple chronic conditions (MCC) is certainly one of the most compelling healthcare challenges [1]. Most of the available data about MCC derive from large administrative... more

FIB-4 score association with operative outcomes, truth or fibs?

12 September 2024
Author(s): Brandon Stretton, Joshua Kovoor, Edmund Tse, Guy Maddern, Stephen Bacchi, Study group investigators

In recent years, liver disease has become established as a significant predictor of poor perioperative outcomes [1]. Despite declining rates of hepatitis B and hepatitis C-related morbidity and... more

Diagnostic value of pleural calprotectin in differentiating complex parapneumonic effusions

6 September 2024
Author(s): Ourania S. Kotsiou, Nikolaos D. Karakousis, Dimitrios Papagiannnis, Garyfallia Perlepe, Konstantinos I. Gourgoulianis

Dear Editor,

Oh no, all we needed was monkeypox!

3 September 2024
Author(s): Giuseppe Lippi

Four years after the spread of the coronavirus disease 2019 (COVID-19) pandemic, with a worldwide epidemiology largely under control thanks to widespread immunity against severe acute respiratory... more

Original Article

Assessment of nasal pressure swing predicts respiratory support dependency in patients with hypoxic respiratory failure

7 March 2025
Author(s): Roberto Tonelli, Giulia Bruzzi, Riccardo Fantini, Luca Tabbì, Antonio Moretti, Francesco Livrieri, Ivana Castaniere, Stefania Cerri, Daniele Puggioni, Federico Guidotti, Gianluca Bellesia, Alessandro Marchioni, Enrico Clini

In recent years, particularly following the COVID-19 pandemic, there has been increasing interest in non-invasive respiratory support (RS) to manage the acute hypoxemic respiratory failure (AHRF) [1–... more

Assessment of cardiovascular, thromboembolic and cancer risk in patients eligible for treatment with Janus Kinase inhibitors: The JAK-ERA multidisciplinary consensus

20 February 2025
Author(s): Lorenzo Dagna, Alessia Alunno, Nicola Farina, Giancarlo Agnelli, Claudio Borghi, Roberto Caporali, Antonio Costanzo, Silvio Danese, Filippo De Braud, Gian Domenico Sebastiani, Carlo Maurizio Montecucco

Janus kinase inhibitors (JAKi), a class of targeted synthetic disease-modifying antirheumatic drugs, have significantly impacted clinical practice in the treatment of various autoimmune and... more

Promoting women's careers in life science and medicine: A position paper from the “International Women in Intensive Medicine” network

15 February 2025
Author(s): Olfa Hamzaoui, Florence Boissier, Carla Teixera, Luciana Mascia, Irene Aragao, Sahar Bahrami, Maria Cruz Martin Delgado, Jannicke Mellin-Oslen, Jordi Rello, Francesca Rubulotta, iWIN network members in annex 1

It is well-established that women are underrepresented in leadership positions [1], undervalued in their academic careers, and experience gender discrimination in scientific and healthcare... more

Hypertensive heart disease in older patients: considerations for clinical practice

15 February 2025
Author(s): Miguel Camafort, Alexandros Kasiakogias, Enrico Agabiti-Rosei, Stefano Masi, Panagiotis Iliakis, Athanase Benetos, Jin-Ok Jeong, Hae-Young Lee, Maria Lorenza Muiesan, Isabella Sudano, Costas Tsioufis, European Society of Hypertension Working Group on Hypertension and the Heart

Appropriate blood pressure (BP) control remains the main therapeutic strategy to address the adverse sequelae of hypertension irrespective of a patient's age [1]. A patient group that is continuously... more

Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study

13 February 2025
Author(s): Joost Boeckmans, Linnea Widman, Ying Shang, Rickard Strandberg, Axel Wester, Jörn M Schattenberg, Hannes Hagström

Patients with a chronic liver disease often develop liver cirrhosis after a certain time if their disease is not appropriately managed, and cirrhosis was the cause of death in 2.4 % of all deaths... more

Clinical familial hypercholesterolemia - factors influencing diagnosis and cardiovascular risk in the general population

13 February 2025
Author(s): Frida Toft-Nielsen, Frida Emanuelsson, Børge G Nordestgaard, Marianne Benn

Heterozygous familial hypercholesterolemia (FH) is an autosomal, dominant disorder of lipoprotein metabolism. The disease is estimated to affect 1:250 of individuals in Western populations [1–3].... more

Comparative analysis of obesity indices in discrimination and reclassification of cardiovascular disease risk: The ATTICA study (2002–2022)

11 February 2025
Author(s): Sofia-Panagiota Giannakopoulou, Fotios Barkas, Christina Chrysohoou, Evangelos Liberopoulos, Petros P. Sfikakis, Christos Pitsavos, Costas Tsioufis, Demosthenes Panagiotakos

In the mid-2010s, after four decades of consistent decline, the mortality rate from heart disease began to show an increasing trend. This shift was largely attributed to the growing obesity epidemic... more

Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis

11 February 2025
Author(s): Marco Canepa, Gianluca Anastasia, Pietro Ameri, Rocco Vergallo, Christopher M. O'Connor, Gianfranco Sinagra, Italo Porto

Heart failure (HF) is a major cause of cardiovascular (CV) morbidity and mortality in developed countries with rising prevalence due to the aging of the population, the poor control of CV risk... more

Advancing women's health with a pioneering implant to treat breast cancer related lymphedema

11 February 2025
Author(s): L. Mazzolai, V. Triacca, M.J. Brochu-Vez, V. Boucard, M. Aberle, V. Chaplet, V. Ferrari, S. Déglise, M. Pisano, S. Staubli

Lymphedema (LE) is a frequent, but often overlooked condition, with secondary LEs accounting for approximately 82.5% of cases [1]. It typically arises from lymphatic vessel damage or obstruction... more

High-flow nasal oxygen therapy in patients with hypercapnic respiratory failure: A systematic review and meta-analysis

8 February 2025
Author(s): Lili Guan, Jianyi Niu, Qiaoyun Huang, Shanshan Zha, Zhenfeng He, Jieying Hu, Shengchuan Feng, Luqian Zhou, Rongchang Chen

Noninvasive ventilation (NIV) has been used to treat acute respiratory failure for more than 30 years, and it is undoubtedly one of the most important advances in respiratory support [1]. With the... more

Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study

31 January 2025
Author(s): Elena Olmastroni, Julius L. Katzmann, Federica Galimberti, Ulrich Laufs, Alberico L. Catapano

Lipoprotein(a) [Lp(a)] is an apoB-containing lipoprotein bound to a hydrophilic, highly glycosylated protein called apolipoprotein(a) [apo(a)] [1]. Apo(a) is encoded by the LPA gene, and Lp(a)... more

Opt-In versus opt-out for the secondary use of routinely recorded health data: A randomized controlled trial

29 January 2025
Author(s): Merel Hermus, Celinde H. Scharloo-Karels, M. Arfan Ikram, Eleni-Rosalina Andrinopoulou, Dimitris Rizopoulos, Dennis H. Marck, Michelle Michels, Folkert van Kemenade

Optimal data availability is crucial for continuous improvement and innovation in healthcare. In moving toward learning health systems, data need to be constantly generated, reused and learned from.... more

Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis

29 January 2025
Author(s): Edoardo Pirera, Domenico Di Raimondo, Lucio D'Anna, Antonino Tuttolomondo

Chronic obstructive pulmonary disease (COPD) is primarily a respiratory condition characterized by irreversible airflow limitation and multiple debilitating symptoms, including dyspnea, cough, and... more

Prediction of mortality in heart failure by machine learning. Comparison with statistical modeling

28 January 2025
Author(s): Domenico Scrutinio, Federica Amitrano, Pietro Guida, Armando Coccia, Gaetano Pagano, Gianni D'addio, Andrea Passantino

Heart failure (HF) is a complex, increasingly prevalent syndrome burdened by poor quality of life, compromised capability to accomplish activities of daily living, high healthcare costs, and still... more

Safety and efficacy of early initiation of sodium-glucose co-transporter inhibitors 2 in patients hospitalized for acute heart failure: A meta-analysis of randomized controlled trials

21 January 2025
Author(s): Renzo Laborante, Donato Antonio Paglianiti, Emiliano Bianchini, Mattia Galli, Josip Andelo Borovac, Gianluigi Savarese, Giuseppe Patti, Domenico D'Amario

Acute heart failure (HF) is a clinical syndrome with multiple aetiologies, among which acute coronary syndrome constitutes one of the most frequent precipitating factors, especially in developed... more

Comparative effectiveness of bictegravir versus dolutegravir, raltegravir, and efavirenz-based antiretroviral therapy among treatment-naïve individuals with HIV

21 January 2025
Author(s): Isaac Núñez, Yanink Caro-Vega, Conor MacDonald, Juan Luis Mosqueda, Alicia Piñeirúa-Menéndez, Anthony A. Matthews

Bictegravir or dolutegravir (two integrase strand inhibitors) in combination with two nucleoside reverse transcriptase inhibitors are recommended as first-line antiretroviral therapy [1,2].Both have... more

What is the impact of thiamine deficiency on cognitive function in patients with alcohol use disorder? – A systematic review

15 January 2025
Author(s): Joana Teixeira, Inês Pereira, Miguel Castanho, Frederico Simões do Couto

Cognitive impairments, frequently observed in Alcohol Use Disorder (AUD) patients, range from severe memory impairment with other cognitive functions relatively preserved seen in Korsakoff's Syndrome... more

Effects of population-based screening for atrial fibrillation on quality of life

12 January 2025
Author(s): Emilie Katrine Kongebro, Christian Kronborg, Lucas Yixi Xing, Ketil Jørgen Haugan, Claus Graff, Søren Højberg, Morten S Olesen, Derk Krieger, Axel Brandes, Lars Køber, Jesper Hastrup Svendsen, Søren Zöga Diederichsen

Atrial fibrillation (AF) is the most common cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, and mortality [1]. Many cases of AF remain undetected due to no or... more

The impact of hypoalbuminemia on the long-term prognosis of patients with acute heart failure: The modifying role of carbohydrate antigen 125

3 January 2025
Author(s): Pau Llàcer, François Croset, Rafael de la Espriella, Marina García, Gema Miñana, Jorge Campos, Enrique Santas, Carlos Pérez, Miguel Lorenzo, Alberto Pérez, Gonzalo Núñez, Esteban Pérez, Luis Manzano, Julio Núñez

The main novelty of the present study is:

Adverse effects of late sleep on physical health in a large cohort of community-dwelling adults

31 December 2024
Author(s): Renske Lok, Lara Weed, Joseph Winer, Jamie M. Zeitzer

Human health is influenced by a myriad of factors, including genetics, environment, and behavior. One behavior that has received significant recent attention is the impact of sleep on human health.... more

Prevalence and impact of multidrug resistance in a cohort of patients admitted to emergency department for urinary tract-infections: The UTILY study, a prospective multicentre study

30 December 2024
Author(s): Lorenzo Onorato, Enrico Allegorico, Margherita Macera, Caterina Monari, Biagio Migliaccio, Carmine Nasta, Maria Teresa Florio, Roberta Sciorio, Fabio Giuliano Numis, Giovanna Guiotto, Mauro Giordano, Rosa Raucci, Ferdinando Dello Vicario, Rodolfo Nasti, Antonio Voza, Nicola Coppola, for UTILY study group

Urinary tract infections (UTIs) are among the most frequent bacterial infections both in community and healthcare settings [1]. The Global Burden of Diseases (GBD) has estimated an incidence of 0.4... more

The effect of a new thinking guidance of OPACCUS for shock on the 30-day mortality: A multicenter, prospective, observational, cohort study

26 December 2024
Author(s): Yi Li, Tongjuan Zou, Xueying Zeng, Yao Qin, Ran Zhou, Lianghai Cao, Jian Hu, Xianying Lei, Qionglan Dong, Yiwei Qin, Ge Zhang, Yan Kang, Bo Wang, Zhongwei Zhang, Xiaoting Wang, Yangong Chao, Wanhong Yin, Critical Care Ultrasound Study Group (CCUSG); Committee on Critical Care Ultrasound and Hemodynamics (CCUSH, SCIMEA)

Shock is the final common pathway before death and a constant focus of ICU physicians due to its high morbidity and mortality [1] (ranging from 27 % to 60 %) in critically ill patients. Recent... more

Effects of valsartan vs amlodipine and achieved lower blood pressure on the incidence of end-stage kidney disease: The VALUE Trial

18 December 2024
Author(s): Eirik Olsen, Kenneth Jamerson, Roland E. Schmieder, Camilla L. Søraas, Julian E. Mariampillai, Giuseppe Mancia, Sverre E. Kjeldsen, Sondre Heimark, Maria H. Mehlum, Knut Liestøl, Anne C.K. Larstorp, Lene V. Halvorsen, Aud Høieggen, Michel Burnier, Morten Rostrup, Stevo Julius, Michael A. Weber

There is a strong relationship between high blood pressure (BP) and the risk of developing chronic kidney disease (CKD) [1–8]. In people with CKD, a high BP is associated with a faster decline of... more

Length of hospital stay, delayed pneumonia diagnosis and post-discharge mortality. The Pneumonia in Italian Acute Care for Elderly units (PIACE)-SIGOT study

18 December 2024
Author(s): Filippo Luca Fimognari, Paolo Fabbietti, Francesco Baffa Bellucci, Andrea Corsonello, Roberto Ricchio, Massimo Rizzo, Olga Cuccurullo, Alberto Ferrari, Lorenzo Palleschi, PIACE-SIGOT Investigators

The ageing of populations in high-income countries has increased the number of vulnerable older persons requesting medical care, including care for acute and complex illnesses that warrant medical... more

Effect of continuous positive airway pressure on non-fatal stroke and paroxysmal atrial fibrillation recurrence in obstructive sleep apnoea elderly patients

16 December 2024
Author(s): Valentino Condoleo, Giandomenico Severini, Giuseppe Armentaro, Mattea Francica, Giulia Crudo, Mario De Marco, Francesco Maruca, Guglielmo Ciaccio, Carlo Fuoco, Carlo Alberto Pastura, Marcello Divino, Corrado Pelaia, Egidio Imbalzano, Mario Bo, Andrea Ungar, Angela Sciacqua

Obstructive sleep apnoea (OSA) is a respiratory disorder characterised by repeated events of upper airway collapse leading to airflow limitation [1]. OSA is often under-recognised, and if untreated,... more

Exploring phenotypes to improve long-term mortality risk stratification in obstructive sleep apnea through a machine learning approach: an observational cohort study

16 December 2024
Author(s): Pasquale Tondo, Giulia Scioscia, Sebastien Bailly, Roberto Sabato, Terence Campanino, Piera Soccio, Maria Pia Foschino Barbaro, Crescenzio Gallo, Jean-Louis Pépin, Donato Lacedonia

Obstructive sleep apnea (OSA) is a highly prevalent [1] and heterogeneous sleep disorder [2], characterized by frequent collapses of the upper airway that induce intermittent hypoxia and sleep... more

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

13 December 2024
Author(s): Giosiana Bosco, Francesco Di Giacomo Barbagallo, Maurizio Di Marco, Sabrina Scilletta, Nicoletta Miano, Stefania Capuccio, Marco Musmeci, Stefania Di Mauro, Agnese Filippello, Alessandra Scamporrino, Antonino Di Pino, Luis Masana, Francesco Purrello, Salvatore Piro, Roberto Scicali

Atherosclerosis is a chronic and progressive process promoted by several environmental and genetic factors [1,2]; among these, low-density lipoprotein cholesterol (LDL-C) has been recognized to have... more

Long-term follow-up of hereditary hemorrhagic telangiectasia patients without significant pulmonary right-to-left shunt at screening

11 December 2024
Author(s): Bernat Villanueva, Miguel Ángel Sánchez-Corral, Esther Alba, Queralt Ordi, Yolanda Ruiz, Raquel Torres-Iglesias, Alejandro Portillo, Adriana Iriarte, Cristina Monforte, Enric Gamundí, Xavier Pintó, Jesús Ribas, Antoni Riera-Mestre

Hereditary hemorrhagic telangiectasia (HHT) is a vascular genetic rare disease (ORPHA: 774) characterized by systemic telangiectases and larger vascular malformations [1]. HHT can be diagnosed using... more

Different impact of chronic kidney disease in older patients with heart failure according to frailty

7 December 2024
Author(s): Pablo Díez-Villanueva, César Jiménez-Méndez, Ángel Pérez-Rivera, Eduardo Barge Caballero, Javier López, Carolina Ortiz, Clara Bonanad, Josebe Goirigolzarri, Alberto Esteban Fernández, Marta Cobo, Nuria Montes, Albert Ariza-Solé, Manuel Martínez-Sellés, Fernando Alfonso

Chronic kidney disease (CKD) affects up to 10 % of the general population, being one-third of these individuals over 65 years old [1]. A bidirectional interaction, has been described between CKD and... more

Association between long-term exposure to air pollution and incidence of peripheral artery disease: Evidence from a longitudinal study

5 December 2024
Author(s): Chiara Di Blasi, Federica Nobile, Alberto Maria Settembrini, Massimo Stafoggia, Marina Davoli, Paola Michelozzi, Matteo Renzi, Pier Mannuccio Mannucci

Cardiovascular disease (CVD) is one the most frequent cause of death and disability globally, including Europe. CVD causes 3.9 million annual deaths in the European Union and the loss of 26 million... more

Comorbidity patterns and the risk of injurious falls in older people with atrial fibrillation: Findings from a Swedish nation-wide population-based study

30 November 2024
Author(s): Caterina Trevisan, Cecilia Damiano, Lu Dai, Amaia Calderón-Larrañaga, Jonas W. Wastesson, Kristina Johnell, Cheïma Amrouch, Graziano Onder, Alessandra Marengoni, Riccardo Proietti, Gregory Y H Lip, Søren P Johnsen, Mirko Petrovic, Davide Liborio Vetrano, on behalf of the AFFIRMO Consortium

Atrial fibrillation (AF) is the most common arrhythmia in the general population, increasing by 30 % over the last 20 years primarily as a result of the better diagnostics and ageing population [1],... more

Clinical characteristics and outcomes of Takotsubo syndrome in patients with chronic obstructive pulmonary disease

7 November 2024
Author(s): Luca Arcari, Giacomo Tini, Michela Zuccanti, Giovanni Camastra, Alessandro Cianca, Emanuela Belmonte, Giulio Montefusco, Riccardo Scirpa, Claudia Malerba, Fabrizio Lupparelli, Matteo Sclafani, Viviana Maestrini, Beatrice Musumeci, Emanuele Barbato, Luca Cacciotti

Takotsubo syndrome (TTS) is an acute heart failure syndrome characterized by a transient impairment of systolic function [1]. Adverse outcomes have been described both in the acute phase and, despite... more

Modifiable lifestyle factors in the primordial prevention of hypertension in three US cohorts

6 November 2024
Author(s): Rikuta Hamaya, Molin Wang, Ellen Hertzmark, Nancy R Cook, JoAnn E Manson, Qi Sun, Meir J Stampfer, Kenneth J. Mukamal, Gary Curhan, Eric B Rimm

Hypertension is a leading cause of cardiovascular diseases (CVD). The prevalence has doubled from 1990 to 2019 [1] and now impacts almost half of the US adult population [2], and the condition... more

Clinically relevant bleeding according to location of metastases in cancer-associated thrombosis

28 October 2024
Author(s): Victor Garcia-Garcia, Maria Barca-Hernando, Sergio Lopez-Ruz, Carmen Rosa-Linares, Teresa Elias-Hernandez, Remedios Otero-Candelera, Henry Andrade-Ruiz, Luis Jara-Palomares

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a frequent complication in patients with cancer [1]. It is estimated that 20–30 % of VTE cases are... more

External validation of a prognostic score to identify low-risk outpatients with acute deep venous thrombosis in the lower limbs

14 October 2024
Author(s): Francisco Galeano-Valle, Rubén Alonso-Beato, Sergio Moragón-Ledesma, Tatiana Pire-García, Olaya Huergo-Fernández, Lucía Ordieres-Ortega, Crhistian-Mario Oblitas, Luis Antonio Alvarez-Sala Walther, Pablo Demelo-Rodríguez

Deep vein thrombosis (DVT) and pulmonary embolism (PE) stand as the primary manifestations of venous thromboembolism (VTE) [1-3]. Nonetheless, the absence of national surveillance systems for VTE... more

Hyperchloremic metabolic acidosis potentially benefiting sodium bicarbonate therapy: A multi-center cohort study

11 October 2024
Author(s): Lingfei Tong, Shuiyan Wu, Deping Li, Yanmei Cao, Huaqing Liu

Metabolic acidosis is a type of acid-base imbalance that significantly impacts prognosis. It can be caused by poisoning, infections, surgeries, acute and chronic renal failure, diabetic ketosis, and... more

Practice Guidelines

Treatment of hospitalized patient with hyperglycemia: An EFIM critically appraised and adapted guideline

9 December 2024
Author(s): Oğuz Abdullah Uyaroğlu, Ieva Ruza, Jan Skrha, Dimitrios Patoulias, Sebastjan Bevc, Biljana Ivanovska Bojadjiev, Ricardo Gómez-Huelgas, Jörg Bojunga, Wiktoria Lesniak, Juana Carretero-Gómez, Julio Wacker, Luis M. Pérez-Belmonte, Dror Dicker, Tadej Petreski, Ignacio Marín-León

Over the past decade, diabetes mellitus (DM) has emerged as a growing epidemic with an estimated global prevalence of 10.5 % (537 million people) in 2021, according to the International Diabetes... more

Review Article

Comprehensive management of pneumonia in older patients

27 February 2025
Author(s): Alain Putot, Nicolas Garin, Jordi Rello, Virginie Prendki, European Study Group of Infections in the Elderly Patients (ESGIE).

Pneumonia is a bacterial, viral, fungal, or parasitic infection of lung parenchyma, resulting in significant local and systemic inflammation. Pneumonia is the leading infectious cause of... more

Bridging the gap: Time to integrate sex and gender differences into research and clinical practice for improved health outcomes

6 February 2025
Author(s): Roberta Gualtierotti

It is widely recognized that sex and gender interact with factors such as genetic background, ethnicity, socioeconomic status, disability, and age, thus influencing health status and disease. The... more

Beyond creatinine: New methods to measure renal function?

31 January 2025
Author(s): M. Salman Sheikh, Kianoush B. Kashani

The kidneys play a central role in maintaining the body's homeostasis, performing a wide range of vital functions. They eliminate unnecessary and potentially toxic metabolic waste products, such as... more

Chronic obstructive pulmonary disease: A narrative synthesis of its hallmarks for palliative care clinicians

9 January 2025
Author(s): Jacopo D'Andria Ursoleo, Alice Bottussi, Donald R. Sullivan, Corrado D'Andria, Natalia Smirnova, William E. Rosa, Stefano Nava, Fabrizio Monaco

Chronic obstructive pulmonary disease (COPD) accounts for approximately 55 % of cases of respiratory diseases and is now the third cause of both death and morbidity worldwide [1]. Its prevalence is... more

Practical management of severe acute pancreatitis

29 November 2024
Author(s): Karim Hamesch, Marcus Hollenbach, Lucía Guilabert, Tobias Lahmer, Alexander Koch

Diagnosis of acute pancreatitis (AP) is based on the Revised Atlanta Classification[1] (Table 1) requiring at least two of three criteria: i) typical epigastric pain radiating to the back, ii) serum... more

Transforming organ donation and transplantation: Strategies for increasing donor participation and system efficiency

20 November 2024
Author(s): David B. Olawade, Sheila Marinze, Nabeel Qureshi, Kusal Weerasinghe, Jennifer Teke

Organ transplantation stands as one of the most significant advancements in modern medicine, providing life-saving solutions for patients with end-stage organ failure [1]. From the first successful... more

New strategies for the treatment of hyperkalemia

2 November 2024
Author(s): Stefano Masi, Herman Dalpiaz, Sara Piludu, Federica Piani, Giulia Fiorini, Claudio Borghi

Potassium (K+) is the most abundant cation in the body (50–75 mEq/L/kg body weight). Under physiological conditions, approximately 98 % of total body K+ is located in the intracellular space and only... more

Gliflozines use in heart failure patients. Focus on renal actions and overview of clinical experience

21 September 2024
Author(s): Edoardo Gronda, Massimo Iacoviello, Arduino Arduini, Manuela Benvenuto, Domenico Gabrielli, Mario Bonomini, Luigi Tavazzi

In the past decades impressive progress in heart failure (HF) treatment has been achieved by adoption of therapeutic tools ranging from renin angiotensin system antagonists to beta blocking agents,... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness